Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2026-08-20 16:30:37 ET · period of report 2026-08-19 · accession 0001907056-26-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-20 16:30 | 2026-08-19 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $5.01 | +4,938 | 269.1K | +2% | +$24.7K |
| DT | 2026-08-20 16:30 | 2026-08-19 | HIMS | Okupe Oluyemi | CFO | S - Sale+OE | $29.99 | -4,938 | 264.1K | -2% | -$148.1K |
| DT | 2026-08-20 16:30 | 2026-08-19 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $0.00 | -4,938 | 80.9K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-08-19 | M | A | 4,938 | $5.01 | 269,055 | D | — | — | (F1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. |
| 2 | Common | Class A Common Stock | 2026-08-19 | S | D | 4,938 | $29.99 | 264,117 | D | — | — | (F1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.0450. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2026-08-19 | M | D | 4,938 | $0.00 | 80,872 | D | $5.01 · — to 2032-02-23 | 4,938 Class A Common Stock | (F1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. (F3) 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. |